Effect of oral supplement of carnitine on hypoglycemia, sepsis and apnea of very low birth weight neonates

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT138707281162N6

Enrollment

Registered

2008-10-29

Start date

2007-03-05

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carnitine supplementation in very low birth weight neonates.

Interventions

carnitine supplemention (20mg/kg/day) up to 11th day of birth.

carnitine supplemention (20mg/kg/day) up to 11th day of birth

Eligibility

Sex/Gender

All

Age

No minimum to 3 Years

Inclusion criteria

Inclusion criteria: Inclusion/Exclusion: Neonates with appropriate for gestational age, birth weight < 1500g, in 3 days of life, without cardiovascular disease, congenital anomaly and respiratory or metabolic diseases. Exclusion: History of diabetes, hypertension, preeclampsia or long fever in mother. Mechanical ventilation, severe hypotension, shock, metabolic disease during the intervention for neonates.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Septicemia. Timepoint: Daily. Method of measurement: Positive blood culture.;Hypoglycemia (serum glucose less than 40 mg/dl). Timepoint: daily. Method of measurement: glucometer.;Apnea. Timepoint: Daily. Method of measurement: Number of apnea episodes (by pulsoximetry).	—

Secondary

Measure	Time frame
Duration of admission in hospital. Timepoint: dailly. Method of measurement: Number of hospitalization days.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Ashraf mohammadzadeh

Neonatal Research Center

mohamadzadeha@mums.ac.ir , mohammadzadeh_ashraf@yahoo.co+98 51 1852 1121

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026